I. Maurice Wormser Memorial Moot Court CompetitionThis year's I. Maurice Wormser Memorial Moot Court Competition concerns two antitrust law issues in the context of the pharmaceutical industry. The court will consider two issues. First, whether the Foreign Trade Antitrust Improvement Act ("FTAIA") is a jurisdictional statute or lays out substantive elements of a Sherman Antitrust Act claim and how broadly courts should interpret it's "direct effect" requirement. Second, how courts should balance patent and antitrust law when considering the legality of reverse payment settlements.
This year, in an effort to be environmentally conscious, we will only distribute the bench memo, the problem, competitor briefs by email. If this is a serious inconvenience, please let the Wormser Editor, Hilda Lui, know (firstname.lastname@example.org or 212-636-6882.)